Items where authors include "Twelves, C.J."

Article

Baird, R.D., Bermejo de Las Heras, B., Ruiz-Borrego, M. et al. (20 more authors) (2025) Camizestrant in combination with three globally approved CDK4/6 inhibitors in women with ER+, HER2- advanced breast cancer: Results from SERENA-1. Clinical Cancer Research, 31 (20). pp. 4244-4254. ISSN 1078-0432

Gregory, W.M., Twelves, C.J., Bell, R. et al. (4 more authors) (2016) Characterizing and quantifying the effects of breast cancer therapy using mathematical modeling. Breast Cancer Research and Treatment, 155 (2). pp. 303-311. ISSN 0167-6806

Twelves, C.J., O'Reilly, S.M., Coleman, R.E. orcid.org/0000-0002-4275-1043 et al. (2 more authors) (1989) Weekly epirubicin for breast cancer with liver metastases and abnormal liver biochemistry. British Journal of Cancer, 60 (6). pp. 938-941. ISSN 0007-0920

Proceedings Paper

Spears, M., Denkert, C., Villagas, S.L. et al. (4 more authors) (2020) Abstract P1-10-08: Assessing immune biomarkers of response to anthracyclines in breast cancer. In: Cancer Research. 2019 San Antonio Breast Cancer Symposium, 10-14 Dec 2019, San Antonio, Texas, USA. American Association for Cancer Research (AACR) .